Athira Pharma Inc (NASDAQ: ATHA) – Not A Clear Buying Opportunity?
Athira Pharma Inc (ATHA) concluded trading on Thursday at a closing price of $0.43, with 4.46 million shares of worth about $1.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -78.16% during that period and on October 31, 2024 the price saw a […]
Athira Pharma Inc (NASDAQ: ATHA) Loses -4.09% From High. Why That Could Change?
Currently, there are 37.88M common shares owned by the public and among those 35.05M shares have been available to trade. Insiders at the company have transacted a total of 16 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, […]